{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:11:57Z","timestamp":1782306717219,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejps.2016.12.021","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T11:01:15Z","timestamp":1482490875000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Towards prostate cancer gene therapy: Development of a chlorotoxin-targeted nanovector for toxic (melittin) gene delivery"],"prefix":"10.1016","volume":"99","author":[{"given":"Zahra","family":"Tarokh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-171X","authenticated-orcid":false,"given":"Hossein","family":"Naderi-Manesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.12.021_bb0005","series-title":"Prostate Cancer","author":"American Cancer Society","year":"2016"},{"key":"10.1016\/j.ejps.2016.12.021_bb0010","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion chlorotoxin inhibits glioma cell invasion via matrix","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2016.12.021_bb0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1023\/A:1014861900478","article-title":"A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight ontransfection efficiency and cytotoxicity","volume":"16","author":"Fischer","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2016.12.021_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11060-011-0763-6","article-title":"Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs","volume":"107","author":"Fu","year":"2012","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.ejps.2016.12.021_bb0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.etap.2013.06.009","article-title":"Melittin: a lytic peptide with anticancer properties","volume":"36","author":"Gajski","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejps.2016.12.021_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1098\/rsif.2009.0260","article-title":"Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery","volume":"7","author":"Grigsby","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.ejps.2016.12.021_bb0035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-5347(05)65742-4","article-title":"Gene therapy for prostate cancer: current status and future prospect","volume":"166","author":"Harrington","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.ejps.2016.12.021_bb0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2009.11.006","article-title":"Non-viral gene delivery carrier and its three-dimensional transfection system","volume":"386","author":"He","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.021_bb0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.01.002","article-title":"Arthropod venoms and cancer","volume":"57","author":"Heinen","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.ejps.2016.12.021_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biologicals.2006.08.004","article-title":"Optimization of 25kDa linear polyethylenimine for efficient gene delivery","volume":"35","author":"Huh","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.ejps.2016.12.021_bb0055","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/nn1008512","article-title":"Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma","volume":"4","author":"Kievit","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2016.12.021_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0169-409X(01)00202-2","article-title":"Design and gene delivery activity of modified polyethylenimines","volume":"53","author":"Kircheis","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.12.021_bb0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1166\/jbn.2015.2069","article-title":"Polymeric nanocarriers for non-viral gene delivery","volume":"11","author":"Li","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejps.2016.12.021_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/bi00001a003","article-title":"NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channelst","volume":"34","author":"Lippens","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2016.12.021_bb0075","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jgm.773","article-title":"Recent advances in rational gene transfer vector design based on poly (ethylene imine) and its derivatives","volume":"7","author":"Neu","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ejps.2016.12.021_bb0080","article-title":"Chlorotoxin: structure, activity, and potential uses in cancer therapy","volume":"106","author":"Ojeda","year":"2015","journal-title":"Pept. Sci."},{"key":"10.1016\/j.ejps.2016.12.021_bb0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pros.21296","article-title":"Anti-cancer effect of beevenom in prostate cancer cellsthrough activation of caspase pathway via inactivation of NF-\u03baB","volume":"71","author":"Park","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.ejps.2016.12.021_bb0090","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/biot.200900161","article-title":"Recent trends in non-viral vector-mediated gene delivery","volume":"4","author":"Pathak","year":"2009","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ejps.2016.12.021_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-1523-7","article-title":"Non-viral gene delivery strategies for gene therapy: a \u201cm\u00e9nage \u00e0 trois\u201d among nucleic acids, materials, and the biological environment. Stimuli-responsive gene delivery vectors","volume":"15","author":"Pezzoli","year":"2013","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ejps.2016.12.021_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0090-4295(00)00903-1","article-title":"Gene therapy for prostate cancer","volume":"57","author":"Shalev","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ejps.2016.12.021_bb0105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/pat.3277","article-title":"Tailoring quaternized starch as a non-viral carrier for gene delivery applications","volume":"25","author":"Sieradzki","year":"2014","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ejps.2016.12.021_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4939-2205-5_15","article-title":"Solubilization and refolding of inclusion body proteins","volume":"1258","author":"Singh","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejps.2016.12.021_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2012.11.027","article-title":"Development of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene delivery","volume":"441","author":"Soltani","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.021_bb0120","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin: Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"1","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2016.12.021_bb0125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.biomaterials.2008.10.003","article-title":"A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells","volume":"30","author":"Veiseh","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2016.12.021_bb0130","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.addr.2011.01.010","article-title":"Cancer cell invasion: treatment and monitoring opportunities in nanomedicine","volume":"63","author":"Veiseh","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.12.021_bb0135","series-title":"Chemistry of Protein and Nucleic Acid Cross-Linking and Conjugation","author":"Wong","year":"2012"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T12:50:13Z","timestamp":1536151813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716305619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":27,"alternative-id":["S0928098716305619"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.021","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards prostate cancer gene therapy: Development of a chlorotoxin-targeted nanovector for toxic (melittin) gene delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}